Analyst Rating Changes — Upgrades, Downgrades & Price Targets

37152 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.

Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.

All ↑ Upgrades ↓ Downgrades ◎ Price Targets

Latest Price-Target Changes

WhenStockChange FirmAnalyst RatingPrice Target
Oct 08
17:14 UTC
FCX
Freeport-McMoRan
◎ Target UBS Group Daniel Major ★★★★☆ #460 Buy $77.00→ $88.00+14.3%
Oct 08
17:14 UTC
CVX
Chevron
◎ Target UBS Group Josh Silverstein ★★☆☆☆ #2447 Buy $220.00→ $235.00+6.8%
Oct 08
17:14 UTC
ARCB
ArcBest
◎ Target Stifel Nicolaus J. Bruce Chan ★★★☆☆ #1769 Buy $185.00→ $168.00-9.2%
Oct 08
17:14 UTC
AMR
Alpha Metallurgical Resources
◎ Target UBS Group George Eadie ★★★☆☆ #1873 Neutral $160.00→ $180.00+12.5%
Oct 08
16:14 UTC
UTHR
United Therapeutics
◎ Target Royal Bank Of Canada Lisa Walter ★★☆☆☆ #2773 Outperform $677.00→ $708.00+4.6%
Oct 08
16:14 UTC
TRGP
Targa Resources
◎ Target Barclays Theresa Chen ★★★☆☆ #1983 Overweight $284.00→ $294.00+3.5%
Oct 08
16:14 UTC
TPG
TPG
◎ Target Barclays Benjamin Budish ★★★☆☆ #2230 Overweight $64.00→ $60.00-6.2%
Oct 08
16:14 UTC
STZ
Constellation Brands
◎ Target Deutsche Bank Aktiengesellschaft Steve Powers not yet tracked Hold $136.00→ $127.00-6.6%
Oct 08
16:14 UTC
SHLS
Shoals Technologies Group
◎ Target Barclays Christine Cho ★★★★★ #233 Overweight $10.00→ $11.00+10.0%
Oct 08
16:14 UTC
RYTM
Rhythm Pharmaceuticals
◎ Target Royal Bank Of Canada Lisa Walter ★★☆☆☆ #2773 Outperform $155.00→ $159.00+2.6%
Oct 08
16:14 UTC
LW
Lamb Weston
◎ Target Barclays Andrew Lazar ★★★☆☆ #1942 Overweight $56.00→ $58.00+3.6%
Oct 08
16:14 UTC
LEVI
Levi Strauss & Co.
◎ Target Barclays Adrienne Yih ★★★☆☆ #1643 Overweight $27.00→ $26.00-3.7%
Oct 08
16:14 UTC
KKR
KKR & Co. Inc.
◎ Target Barclays Benjamin Budish ★★★☆☆ #2230 Overweight $135.00→ $130.00-3.7%
Oct 08
16:14 UTC
CSTM
Constellium
◎ Target Deutsche Bank Aktiengesellschaft Corinne Blanchard ★★★☆☆ #2206 Buy $39.00→ $36.00-7.7%
Oct 08
16:14 UTC
CLH
Clean Harbors
◎ Target Barclays William Grippin ★★☆☆☆ #2563 Equal Weight $325.00→ $335.00+3.1%
Oct 08
16:14 UTC
CG
Carlyle Group
◎ Target Barclays Benjamin Budish ★★★☆☆ #2230 Overweight $64.00→ $53.00-17.2%
Oct 08
16:14 UTC
BX
Blackstone
◎ Target Barclays Benjamin Budish ★★★☆☆ #2230 Equal Weight $128.00→ $124.00-3.1%
Oct 08
16:14 UTC
AEM
Agnico Eagle Mines
◎ Target UBS Group Daniel Major ★★★★☆ #460 Neutral $170.00→ $190.00+11.8%
Oct 08
15:14 UTC
VRTX
Vertex Pharmaceuticals
◎ Target Royal Bank Of Canada Brian Abrahams ★★☆☆☆ #2565 Outperform $570.00→ $576.00+1.1%
Oct 08
15:14 UTC
SAP
SAP
◎ Target BMO Capital Markets Keith Bachman ★★★★☆ #848 Outperform $177.00→ $235.00+32.8%
Oct 08
15:14 UTC
RVMD
Revolution Medicines
◎ Target Royal Bank Of Canada Leonid Timashev ★★★☆☆ #2010 Outperform $251.00→ $259.00+3.2%
Oct 08
15:14 UTC
ONC
BeOne Medicines
◎ Target Royal Bank Of Canada Leonid Timashev ★★★☆☆ #2010 Outperform $450.00→ $459.00+2.0%
Oct 08
15:14 UTC
MIRM
Mirum Pharmaceuticals
◎ Target Royal Bank Of Canada Lisa Walter ★★☆☆☆ #2773 Outperform $135.00→ $155.00+14.8%
Oct 08
15:14 UTC
MGM
MGM Resorts International
◎ Target Susquehanna Joseph Stauff ★★★☆☆ #1351 Positive $46.00→ $41.00-10.9%
Oct 08
15:14 UTC
MC
Moelis & Company
◎ Target Morgan Stanley Ryan Kenny ★☆☆☆☆ #3002 Overweight $85.00→ $77.00-9.4%
Oct 08
15:14 UTC
LEVI
Levi Strauss & Co.
◎ Target Wells Fargo & Company Ike Boruchow ★★★☆☆ #1878 Equal Weight $25.00→ $20.00-20.0%
Oct 08
15:14 UTC
LEGN
Legend Biotech
◎ Target Royal Bank Of Canada Leonid Timashev ★★★☆☆ #2010 Outperform $58.00→ $56.00-3.4%
Oct 08
15:14 UTC
LCLN
Lincoln International
◎ Target Morgan Stanley Ryan Kenny ★☆☆☆☆ #3002 Equal Weight $28.00→ $27.00-3.6%
Oct 08
15:14 UTC
LAZ
Lazard
◎ Target Morgan Stanley Ryan Kenny ★☆☆☆☆ #3002 Underweight $44.00→ $41.00-6.8%
Oct 08
15:14 UTC
KALU
Kaiser Aluminum
◎ Target KeyCorp Samuel McKinney ★★★★☆ #578 Overweight $183.00→ $181.00-1.1%
Oct 08
15:14 UTC
JAZZ
Jazz Pharmaceuticals
◎ Target Royal Bank Of Canada Leonid Timashev ★★★☆☆ #2010 Outperform $299.00→ $296.00-1.0%
Oct 08
15:14 UTC
INCY
Incyte
◎ Target Royal Bank Of Canada Brian Abrahams ★★☆☆☆ #2565 Sec→ r Perform $109.00→ $114.00+4.6%
Oct 08
15:14 UTC
HRI
Herc
◎ Target Wells Fargo & Company Jerry Revich ★★★☆☆ #2021 Overweight $218.00→ $176.00-19.3%
Oct 08
15:14 UTC
HLI
Houlihan Lokey
◎ Target Morgan Stanley Ryan Kenny ★☆☆☆☆ #3002 Overweight $177.00→ $165.00-6.8%
Oct 08
15:14 UTC
FVR
FrontView REIT
◎ Target BMO Capital Markets Eric Borden ★★★☆☆ #1028 Outperform $24.00→ $20.00-16.7%
Oct 08
15:14 UTC
FLUT
Flutter Entertainment
◎ Target Susquehanna Joseph Stauff ★★★☆☆ #1351 Positive $115.00→ $100.00-13.0%
Oct 08
15:14 UTC
EXEL
Exelixis
◎ Target Royal Bank Of Canada Leonid Timashev ★★★☆☆ #2010 Sec→ r Perform $46.00→ $45.00-2.2%
Oct 08
15:14 UTC
DKNG
DraftKings
◎ Target Susquehanna Joseph Stauff ★★★☆☆ #1351 Positive $33.00→ $27.00-18.2%
Oct 08
15:14 UTC
CYTK
Cytokinetics
◎ Target Royal Bank Of Canada Leonid Timashev ★★★☆☆ #2010 Outperform $112.00→ $113.00+0.9%
Oct 08
15:14 UTC
CRS
Carpenter Technology
◎ Target KeyCorp Samuel McKinney ★★★★☆ #578 Overweight $608.00→ $465.00-23.5%
Oct 08
15:14 UTC
CMI
Cummins
◎ Target Wells Fargo & Company Jerry Revich ★★★☆☆ #2021 Overweight $874.00→ $760.00-13.0%
Oct 08
15:14 UTC
BLK
BlackRock
◎ Target Wells Fargo & Company Michael Brown ★★★☆☆ #1489 Overweight $1,245.00→ $1,230.00-1.2%
Oct 08
15:14 UTC
BKH
Black Hills
◎ Target BMO Capital Markets James Thalacker ★★★☆☆ #1729 Outperform $83.00→ $86.00+3.6%
Oct 08
15:14 UTC
AXSM
Axsome Therapeutics
◎ Target Royal Bank Of Canada Leonid Timashev ★★★☆☆ #2010 Outperform $297.00→ $295.00-0.7%
Oct 08
15:14 UTC
ATI
ATI
◎ Target KeyCorp Samuel McKinney ★★★★☆ #578 Overweight $258.00→ $228.00-11.6%
Oct 08
15:14 UTC
AMGN
Amgen
◎ Target Royal Bank Of Canada Luca Issi ★★★☆☆ #1257 Outperform $400.00→ $430.00+7.5%
Oct 08
15:14 UTC
ALSN
Allison Transmission
◎ Target Wells Fargo & Company Jerry Revich ★★★☆☆ #2021 Equal Weight $137.00→ $120.00-12.4%
Oct 08
15:14 UTC
ALNY
Alnylam Pharmaceuticals
◎ Target Royal Bank Of Canada Luca Issi ★★★☆☆ #1257 Outperform $350.00→ $345.00-1.4%
Oct 08
14:14 UTC
VSH
Vishay Intertechnology
◎ Target Oppenheimer Christopher Glynn ★★★★☆ #922 Outperform $42.00→ $45.00+7.1%
Oct 08
14:14 UTC
SRPT
Sarepta Therapeutics
◎ Target Royal Bank Of Canada Brian Abrahams ★★☆☆☆ #2565 Sec→ r Perform $19.00→ $17.00-10.5%
🔒 38 more rating changes on this page — plus filtering by our own analyst accuracy.
A free account unlocks the full daily feed.
‹ Prev 122 / 744 Next ›

Frequently Asked Questions

What are analyst rating changes?

An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.

How is this feed different from other rating trackers?

Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.

How often is the rating-changes feed updated?

The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.

Do analyst upgrades and price-target increases mean I should buy?

No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.